Ryboquin raises £1.8m

Ryboquin raises £1.8m

Scottish drug developer Ryboquin has raised a further £1.8m to progress development of its gene therapy treatment for cancer.  Backers of the Selkirk-based company include existing investors such as Borders business angel group TRI Capital and the Scottish Investment Bank. Read More HERE.